Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects

Circulation

Volumn 96, Issue 10, 1997, Pages 3423-3429

  Vaz, Mario ^a   Jennings, Garry ^a   Turner, Andrea ^a   Cox, Helen ^a   Lambert, Gavin ^a   Esler, Murray ^a,b  

^a ALFRED HOSPITAL   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Hypertension; Nervous system, autonomic; Norepinephrine; Obesity

Indexed keywords

NORADRENALIN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; HEART PROTECTION; HUMAN; HYPERTENSION; MALE; OBESITY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; SYMPATHETIC NERVE; THERMOGENESIS; WEIGHT GAIN;

EID: 0030774228     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.10.3423     Document Type: Article

References (54)

1. Bray GA, York DA, Fisler JS. Experimental obesity: a homeostatic failure due to defective nutrient stimulation of the sympathetic nervous system. Vitam Horm. 1989;45:1-125.
2. Spraul M, Ravussin E, Fontvieille AM, Rising R, Larson DE, Anderson EA. Reduced sympathetic nervous activity: a potential mechanism predisposing to body weight gain. J Clin Invest. 1993; 92:1730-1735.
3. Jung RT, Shetty PS, James WPT. The effect of beta-adrenergic blockade on resting metabolic rate and peripheral thyroid metabolism in obesity. Eur J Clin Invest. 1980;10:179-182.
4. Bielinski R, Schutz Y, Jequier E. Energy metabolism during pos-texercise recovery in man. Am J Clin Nutr. 1985;42:69-82.
5. Schwartz RS, Jaeger LF, Veith RC. Effect of clonidine on the thermic effect of feeding in humans. Am J Physiol. 1988;254: R90-R94.
6. Joy RJT. Responses of cold-acclimatised men to infused norepinephrine. J Appl Physiol. 1963;18:1209-1212.
7. Astrup A, Toubro S, Christensen NJ, Quaade F. Pharmacology of thermogenic drugs. Am J Clin Nutr. 1992;55:246S-248S.
8. Hofstetter A, Schutz Y, Jequier E, Wahren J. Increased 24-hour energy expenditure in cigarette smokers. N Engl J Med. 1986;314: 79-82.
9. Bray GA. Pathophysiology of obesity. Am J Clin Nutr. 1992;55: 488S-494S.
10. Sjostrom L. Morbidity and mortality of severely obese subjects. Am J Clin Nutr. 1992;55:508S-515S.
11. Gordon T, Kannel WB. Obesity and cardiovascular disease: the Framingham study. Clin Endocrinol Metab. 1976;5:367-375.
12. Landsberg L. Diet, obesity and hypertension: a hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis. Q J Med. 1986;236:1081-1090.
13. Di Bona GF. Sympathetic neural control of the kidney in hypertension. Hypertension. 1992;19(suppl I):I-28-I-35.
14. Shepherd JT. Increased systemic vascular resistance and primary hypertension: the expanding complexity. J Hypertens. 1990;8: S15-S27.
15. Bevan RD. Trophic effects of peripheral adrenergic nerves on vascular structure. Hypertension. 1984;6(suppl III):III-19-III-26.
16. Clayton S, Cross M. The aggregation of blood platelets by catecholamines and by Thrombin. J Physiol (Lond). 1963;169:82P.
17. Young JB, MacDonald IA. Sympathoadrenal activity in human obesity: heterogeneity of findings since 1980. Int J Obesity. 1992;16: 959-967.
18. Scherrer U, Randin D, Tappy L, Vollenweider P, Jequier E, Nicod P. Body fat and sympathetic nerve activity in healthy humans. Circulation. 1994;89:2634-2640.
19. Grassi G, Seravalle G, Cattaneo BM, Bolla GB, Lamfranchi A, Colombo M, Giannattasio C, Brunani A, Cavagnini F, Mancia G. Sympathetic activation in obese normotensive subjects. Hypertension. 1995;25:560-563.
20. Esler M, Jackman G, Bobik A, Kelleher D, Jennings G, Leonard P, Skews H, Korner P. Determination of norepinephrine apparent release rate and clearance in humans. Life Sci. 1979;25:1461-1470.
21. Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G. Overflow of catecholamine neurotransmitters to the circulation: source, fate and functions. Physiol Rev. 1990;70:963-985.
22. Esler M, Jennings G, Korner P, Blombery P, Sacharias N, Leonard P. Measurement of total and organ-specific norepinephrine kinetics in humans. Am J Physiol. 1984;247:E21-E28.
23. Cox HS, Kaye DM, Thompson JM, Turner AG, Jennings GL, Itsiopoulos C, Esler MD. Regional sympathetic nervous activation after a large meal in humans. Clin Sci. 1995;89:145-154.
24. Vaz M, Turner A, Kingwell B, Chin J, Koff E, Cox H, Jennings G, Esler M. Postprandial sympatho-adrenal activity: its relation to metabolic and cardiovascular events and to changes in meal frequency. Clin Sci. 1995;89:349-357.
25. Vaz M, Rajkumar C, Wong J, Mazzeo RS, Turner AG, Cox HS, Jennings GL, Esler MD. Oxygen consumption in the heart, hepatomesenteric bed and brain in young and elderly human subjects, and accompanying sympathetic nervous activity. Metabolism. 1996;45: 1487-1492.
26. Vaz M, Cox HS, Kaye DM, Turner AG, Jennings GL, Esler MD. Fallibility of plasma noradrenaline measurements in studying postprandial sympathetic nervous responses. J Auton Nerv Sys. 1995;56: 97-104.
27. Levin BE. Reduced norepinephrine turnover in organs and brains of obesity-prone rats. Am J Physiol. 1995;268:R389-R394.
28. Vollenweider P, Raudin D, Tappy L, Jequier E, Nicod P, Scherrer U. Impaired insulin-induced sympathetic neural activation and vasodilatation in skeletal muscle in obese humans. J Clin Invest. 1994;93:2365-2371.
29. Wallin BG, Esler M, Dorward P, Eisenhofer G, Ferrier C, Westerman R, Jennings G. Simultaneous measurements of cardiac norepinephrine spillover and sympathetic outflow to skeletal muscle in humans. J Physiol. 1992;453:45-56
30. Poehlman ET, Gardner AW, Goran MI, Arciero PJ, Toth MJ, Ades PA, Calles-Escandon J. Sympathetic nervous system activity, body fatness and body fat distribution in younger and older males. J Appl Physiol. 1995;78:802-806.
31. Christin L, O'Connell M, Bogardus C, Danforth E Jr, Ravussin E. Norepinephrine turnover and energy expenditure in Pima Indian and white men. Metabolism. 1993;42:723-729.
32. Masking GJ, Esler MD, Jennings GL, Burton D, Korner PI. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation. 1986;73:615-621.
33. Meredith IT, Broughton A, Jennings GL, Esler MD. Evidence for a selective increase in resting cardiac sympathetic nervous activity in some patients suffering sustained out of hospital ventricular arrythmias. N Engl J Med. 1991;325:618-624.
34. Friberg P, Meredith I, Jennings G, Lambert G, Fazio V, Esler M. Evidence of increased renal noradrenaline spillover rate during sodium restriction in man. Hypertension. 1990;16:121-130.
35. Jackson EK, Li P. Human leptin has natriuretic activity in the rat. Am J Physiol. 1997;272:F333-F338.
36. Messerli FH, Sundgaard-Riise K, Reisin E, Dreslinski G, Dunn FG, Frohlich E. Disparate cardiovascular effects of obesity and arterial hypertension. Am J Med. 1983;74:808-812.
37. Mann DL, Kent RL, Parsons B, Cooper G. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation. 1992; 85:790-804.
38. Hall JE, Brands MW, Hildebrandt DA, Mizelle HL. Obesity-associated hypertension: hyperinsulinemia and renal mechanisms. Hypertension. 1992;19(suppl I):I-45-I-55.
39. Hall JE, Dixon WN, Brands MW, Mizelle HL, Hildebrandt DA. Obesity, hyperinsulinemia, and hypertension: control of renal function and systemic hemodynamics. J Am Soc Nephrol. 1990; 1:490. Abstract.
40. Vollenmeider P, Tappy L, Randin D, Schneiter P, Jequier E, Nicod P, Scherrer U. Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. J Clin Invest. 1993;92:147-154.
41. Baskin DG, Figlewcz DP, Woods SC, Porte D Jr, Dorsa DM. Insulin in the brain. Ann Rev Physiol. 1987;49:335-347.
42. Gudbjornsdottir S, Friberg P, Elam M, Attvall S, Lonnroth P, Wallin BG. The effect of metformin and insulin on sympathetic nerve reactivity, norepinephrine spillover and blood pressure in obese, insulin resistant, normoglycemic, hypertensive men. Blood Press. 1994;3:394-403.
43. Scherrer U, Owlya R, Trueb L. Sympathetic nerve activity before and after resection of an insulinoma. N Engl J Med. 1996;335: 1240-1242.
44. Egawa M, Yoshimatsu H, Bray GA. Effect of corticotropin releasing hormone and neuropeptide Y on electrophysiological activity of sympathetic nerves to interscapular brown adipose tissue. Neuroscience. 1990;34:771-775.
45. Lonnqvist F. The obese gene (ob) and human obesity. News Physiol Sci. 1996;11:147-148.
46. Ribstein J, du Cailar G, Mimram A. Combined renal effects of overweight and hypertension. Hypertension. 1995;26:610-615.
47. Mitchell KD, Braam B, Navar LG. Hypertensinogenic mechanisms mediated by renal actions of the renin-angiotensin system. Hypertension. 1992;19(suppl I):I-18-I-27.
48. Deetjen P, Kramer K. Die Abhangigkeit des O2 Verbrauchs der Niere von der Na-Ruckresorption. Pflugers Arch. 1961;273:636-650.
49. Aksnes AK, Brundin T, Hjeltnes N, Wahren J. Glucose-induced thermogenesis in tetraplegic patients with low sympathoadrenal activity. Am J Physiol. 1994;266:E161-E170.
50. Brundin T, Thorne A, Wahren J. Heat leakage across the abdominal wall and meal induced thermogenesis in normal-weight and obese subjects. Metabolism. 1992;41:49-55.
51. WHO/FAO/UNU. Energy and Protein Requirements. Report of a Joint FAO/WHO/UNU Expert Consultation. Geneva, Switzerland: WHO Technical Report Series; 1985:43.
52. Bazelmans J, Nestel P, O'Dea K, Esler M. Blunted norepinephrine responsiveness to changing energy states in obese subjects. Metabolism. 1985;34:154-160.
53. Sims EAH. Energy balance in human beings: the problems of plentitude. Vitam Horm. 1986;43:1-101.
54. Aneman A, Eisenhofer G, Fandriks L, Friberg P. Hepato mesenteric release and removal of norepinephrine in swine. Am J Physiol. 1995;268:R924-R930.